Explore Biotech Companies

ApiJect provides a single-use injectable delivery system and platform for pharmaceutical and biotech companies to create scalable, affordable prefilled drug injectors.

📍 Durham, NC

Iterum Therapeutics is a clinical-stage pharmaceutical company developing differentiated anti-infectives to combat multi-drug resistant pathogens.

📍 Chicago, IL

Wellinks offers a virtual COPD management platform, utilizing connected devices and coaching for better patient outcomes.

📍 New Haven, CT

Virscio is a contract research organization specializing in translational research and preclinical studies, utilizing NHP models to predict clinical outcomes and advance human health.

📍 New Haven, CT

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio™ (oral nalbuphine ER) for chronic cough.

📍 New Haven, CT

Revalia Bio revolutionizes drug development with Human Data Trials, using real human organ data to accelerate innovation and reduce risk.

📍 New Haven, CT

Rallybio is a clinical-stage biotech company focused on developing transformative therapies for unmet medical needs, particularly in rare diseases.

📍 New Haven, CT

Qx Therapeutics develops innovative drugs, including MAP3K2/3 inhibitors, for acute lung injury and pulmonary diseases.

📍 New Haven, CT

Precipio Diagnostics is a biotech company focused on oncology diagnostics, offering products and services for cancer diagnosis and personalized medicine.

📍 Omaha, NE

OrphAI Therapeutics uses AI to develop novel therapeutics for cancer and rare diseases, including Pulmonary Hypertension associated with Interstitial Lung Disease.

📍 New Haven, CT

Halda Therapeutics develops RIPTAC™ therapeutics, a new precision medicine class for oncology. Acquired by Johnson & Johnson.

📍 New Haven, CT

Cybrexa Therapeutics is a clinical-stage oncology biotech developing novel antigen-independent peptide drug conjugates (ADCs) using its alphalex™ platform.

📍 New Haven, CT

Cellinfinity Bio develops advanced cell therapies using CRISPR and gene editing for solid tumors.

📍 New Haven, CT

Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering antibody-based immunotherapies, leveraging mast cell biology to treat inflammatory, autoimmune, and allergic diseases.

📍 Hampton, NJ

BioXcel Therapeutics is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology using AI. They also focus on sublingual thin film formulation and oral small molecule drugs.

📍 New Haven, CT

Biohaven is a biopharmaceutical company developing small molecule therapies for neurology indications, with a focus on neurological and neuropsychiatric diseases.

📍 New Haven, CT

Bexorg uses donated human brains to discover and validate CNS therapies, aiming to end neurodegenerative diseases.

📍 New Haven, CT

Arvinas is a clinical-stage biotech developing bifunctional small molecules for targeted protein degradation therapeutics to treat debilitating diseases.

📍 New Haven, CT

Artificial Cell Technologies develops proprietary synthetic vaccines using nanofilm-based artificial cells and LbL technology for on-demand, cost-effective production.

📍 New Haven, CT

Alva Health develops patented wearables for remote stroke monitoring and early detection of hemiparesis, aiming to prevent disability.

📍 Dallas, TX

Alphina Therapeutics is a biotech company developing a NAMPT inhibitor for solid tumors, focusing on precision oncology and antibody-drug conjugates.

📍 New Haven, CT

Allyx Therapeutics is a clinical-stage biotech company developing oral therapies, including ALX-001, to reverse neurodegeneration and protect synapses in Alzheimer's and Parkinson's.

📍 New Haven, CT

Acme Monaco is a contract manufacturer of medical devices, specializing in guidewires, springs, stampings, and wire forms since 1947.

📍 New Britain, CT

MCRA is a leading CRO and advisory firm for medical devices, diagnostics, and biologics, specializing in regulatory, clinical, and quality assurance.

📍 New York, NY